NSG BioLabs doubles capacity with new site

The expansion aims to facilitate the growth of promising biotech companies.

Singapore's largest biotech incubator, NSG BioLabs, announced a new facility expansion to support more life sciences companies.

The new second level contains a state-of-the-art Bio-Safety Level 2 laboratory that includes millions of dollars of equipment. It increases NSG BioLabs' total built-up area to 22,000 sq ft.

"In light of the current and expected proliferation of biotech startups, we believe our facility expansion comes at the right time. These promising companies need specialised spaces and equipment to innovate, resulting in major demand for high-quality and well-managed laboratory space that must enable both company and sector growth," said CEO and Founder Daphne Teo. "We have been privileged to support our residents in achieving important breakthroughs within our walls, and we are excited to be able to extend the same support to even more biotech innovators."

Established in late 2019, NSG BioLabs aims to provide a conducive environment for biotech companies in Singapore to grow, scale, and commercialise their operations. The facilities currently have over 20 local and foreign biotech residents, specialising in a diverse range of transformative technologies and life-changing applications such as genome editing, tissue engineering, cellular agriculture, cancer immunotherapy, alternative therapies for liver diseases, artificial intelligence, synthetic biology, neurodegeneration drug discovery, and portable testing for COVID-19 and other pathogens.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The loss will not have any material impact on the company.
Around 66 hotels have submitted to offer their rooms for hotel isolation.
He has been acting as group CEO since September 2021.
Bidding for these projects may commence in the first half of 2022.
Cardholders can now seek treatment from units where they did not register.
The system will be implemented this year.
The new facility will provide care for Indonesians who get treatment overseas.
The system was the only one of its kind in the country.
Healthcare Asia will be back on 3 January 2022. 
The additional patents aim to address supply issues.
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
The gala was held in celebration of World AIDS Day 2021.
It won in the International Human-Machine Competition on Diabetes Management.
The new facility is the first of its kind in Singapore.